phase readout
saveNCT05948020: Efficacy and Safety of Orally Administered Engineered Probiotics (CBT102-A) for the Treatment of Children With Phenylketonuria
COMPLETEDupdated 43m ago
community read0 votes
Sponsor: Children's Hospital of Fudan University. Phase: EARLY_PHASE1. Conditions: Phenylketonuria
view source ↗
comments(0)
5-min edit window · permanent after that